51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03607071 (ClinicalTrials.gov)	May 15, 2018	20/7/2018	Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma	Outcome of Myocardial Inflammation After Steroid Therapy in Thai Systemic Sclerosis Patients: an Ope ...	Myocardial Inflammation	Drug: Prednisolone and taper	Khon Kaen University	NULL	Completed	18 Years	N/A	All	20	Phase 2	Thailand
2	NCT03708718 (ClinicalTrials.gov)	December 21, 2017	8/10/2018	Prednisolone in Early Diffuse Systemic Sclerosis	A Phase II Randomised Study of Oral Prednisolonein Early Diffuse Cutaneous Systemic Sclerosis (Initi ...	Systemic Sclerosis	Drug: Prednisolone 5 mg;Drug: Placebo oral capsule; From August 2020 'no additional treatment'	Prof. Ariane herrick	Versus Arthritis	Completed	18 Years	N/A	All	35	Phase 2	United Kingdom
3	EUCTR2016-002651-25-GB (EUCTR)	11/07/2017	08/05/2018	A Study of Prednisolonein Patients with Early (within 3 years of onset) Diffuse Cutaneous Scleroderm ...	A Phase II Randomised Controlled Study of Oral Prednisolonein Early Diffuse Cutaneous Systemic Scler ...	Early diffuse cutaneous systemic sclerosis MedDRA version: 20.0;Level: LLT;Classification code 10012 ...	Trade Name: Prednisolone 5mg Gastro-resistant Tablets Product Name: Prednisolone 5mg Gastro-resistant T ...	Research Governance and Integrity, University of Manchester	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	72	Phase 2	United Kingdom

First Previous1Next Last